Comment on Shire-Takeda deal gets conditional EU approval, heads to shareholders

Shire-Takeda deal gets conditional EU approval, heads to shareholders

European Union antitrust regulators have conditionally approved Takeda Pharmaceutical Co. Ltd.'s $62 billion bid to acquire Shire plc, a deal that will likely create the largest life sciences employer in Massachusetts. The European Commission said Tuesday that it had approved the acquisition subject to Shire selling an inflammatory bowel disease treatment, called SHP647, that could compete with a Takeda drug if it eventually hits the market.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News